However, the autoimmune nature of IBM has become more solid after the recognition of anti-cytosolic 5′-nucleotidase 1A (anti-cN1A) autoantibodies, which can be detected in 30% to 60% of patients [5]. Here, NT5C1A is linked to inclusion body myositis.